	Impact of catheter positioning on planned target volume (PTV) coverage and organs at risk (OARs) in high-dose-rate (HDR) endotracheal brachytherapy: a comparative 2D vs 3D study. Int J Med Sci Castellón JN, Cacho IF, Carrizosa ML, Villoslada CI, Morcillo MD, Esteban EC, Bueno PS, Zarrabeitia ZZ, Sanz AP, Pérez NC, Avedillo FSM, Gallego MC, Ortega MA, García MS. PMID: 42909360 [PubMed - indexed for MEDLINE]
	Emerging antibody-drug conjugates in lung cancer: highlights from the 2026 ASCO Annual Meeting. Front Oncol Wang X, Miao J, Bao Y, Wang W, Yan X, Wang M, Shen H. PMID: 42909136 [PubMed]
	Development and internal validation of a predictive model for clinical deterioration in newly diagnosed lung cancer patients based on interpretable machine learning. Front Med (Lausanne) Li H, Li Y, Huang X, Zhang Z, Liu Q, Chen Q. PMID: 42908942 [PubMed]
	Antibody-drug conjugates in advanced small-cell lung cancer: a systematic review and single-arm meta-analysis of later-line monotherapy. Front Immunol Chen X, Li S, Li H. PMID: 42908912 [PubMed - indexed for MEDLINE]
	Clinical characteristics and prognostic analysis of patients with connective tissue disease complicated by non-small cell lung cancer. Am J Cancer Res Zhang G, Ding Q, Zhang L, Jiang M, Luo J, Shen Y, Liu J, Wang Y. PMID: 42908716 [PubMed]
	Perioperative and oncological outcomes of single-port versus two-port thoracoscopic lobectomy for non-small cell lung cancer: a propensity score-matched retrospective study. Am J Cancer Res Li W, Yang X, Hao X, Ke L, Wei B. PMID: 42908704 [PubMed]
	InDuRanS: neoadjuvant immunochemotherapy followed by surgery or definitive chemoradiotherapy and consolidation durvalumab in resectable and borderline resectable stage IIB-IIIA/B non-small-cell lung cancer. Front Oncol Gkika E, Waller CF, Dejonckheere CS, Layer JP, Meiners J, Brossart P, Rodermann E, Schiefer AS, Münter M, Nicolay NH, Grosu AL, Rimner A, Schmidt J, Schmid S. PMID: 42908627 [PubMed]
	Emerging Roles of Gold Nanoparticles in Lung Cancer Diagnosis and Imaging: A Promising yet Underexplored Frontier. Asia Pac J Clin Oncol Sharma S, Chadha VD. PMID: 42908350 [PubMed - as supplied by publisher]
	Developing a prediction model to predict the incidence of metastasis in lung cancer patients using artificial intelligence techniques. BMC Pulm Med Gharabaghi MA, Gholamzadeh M. PMID: 42907991 [PubMed - indexed for MEDLINE]
	Clinical and pathological characteristics, immune microenvironment, and survival analysis of molecular subtypes of surgically resected small cell lung cancer. BMC Cancer Tian J, He J, Tian H, Hou X, Liu D. PMID: 42907953 [PubMed - indexed for MEDLINE]
	LLM-assisted multidisciplinary decision-making in lung cancer: efficacy of Gemini-2.5-Pro and GPT-5 in a real-world MDT setting. BMC Med Inform Decis Mak Zhou Z, Wang M, Li J, Wang Z, Lv H. PMID: 42907951 [PubMed - indexed for MEDLINE]
	ACR lung-RADS: updates and future directions. Cancer Imaging Petranovi, Prosper AE, Hunsaker AR, Lam S, Christensen JD. PMID: 42907936 [PubMed - indexed for MEDLINE]
	Utility and Safety of a Novel Preoperative Marking via Ultrathin Bronchoscopy in Thoracic Surgery. Lung Kimura H, Ito T, Nakamura S, Kinoshita F, Baba T, Nakanishi K, Kadomatsu Y, Ueno H, Kato T, Mizuno T, Ishii M, Toyofumi CF. PMID: 42907568 [PubMed - indexed for MEDLINE]
	Full-Cohort Organ Dose Assessment from Low-Dose CT Lung Cancer Screening in the National Lung Screening Trial. Acad Radiol Lee C, Moroz B, Hwang EJ, Hong HS, Yoon SH. PMID: 42907269 [PubMed - as supplied by publisher]
	Adebrelimab combined with apatinib and chemotherapy for neoadjuvant therapy and biomarker analysis in limited-stage small cell lung cancer: study protocol for a single-arm trial. BMJ Open Jin Y, Lu W, Lou L, Zeng J, Fan Y, Chen D. PMID: 42907122 [PubMed - in process]
	The prognostic value of physical functioning on survival in patients with nonsmall cell lung cancer: a systematic review and meta-analysis. Eur Respir Rev Arents E, Haesevoets S, Van Overbeke M, Quadflieg K, Van Hulle F, Salhi B, Criel M, Stevens D, Ruttens D, Surmont V, Daenen M, Derom E, Burtin C, Demeyer H. PMID: 42906942 [PubMed - indexed for MEDLINE]
	Carcinoids of the lung caused by exogenous noxious agents: a scoping review. Eur Respir Rev Kilo S, Schröder C, Frei-Stuber L, Jöckel KH, Jonigk D, Länger F, Nowak D. PMID: 42906939 [PubMed - indexed for MEDLINE]
	Interventions to increase participation in lung cancer screening programmes: a systematic review and meta-analysis. Eur Respir Rev Djuric O, Guida A, Bononi F, Venturelli F, Bassi MC, Gorini G, Paci E, Mantellini P, Giorgi Rossi P. PMID: 42906938 [PubMed - indexed for MEDLINE]
	Lung Cancer Organoid Models for Studying Resistance to Anti-Angiogenic Therapy: Mechanisms and Applications. Crit Rev Oncol Hematol Lin H, Wang K, Chen H, Tan G, Zhu J, Liu H, Yang J. PMID: 42906731 [PubMed - as supplied by publisher]
	How to plan and deliver lung cancer reirradiation: A consensus approach from the ESTRO reirradiation and lung focus groups and ReCOG. Radiother Oncol Hoffmann L, Matrosic CK, Andratschke N, Appelt A, Beddok A, Bergman A, Duffton A, Dunne EM, Gan GN, Mayo C, Murrell DH, O'Dwyer N, Palma D, Velec M, Willmann J, Yorke E, Popovic M, Simone Ii CB. PMID: 42906635 [PubMed - as supplied by publisher]

Articles 1 - 20 / 162898

Page 1 of 8145



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy